At a May congressional briefing, experts shared their perspectives on why a reinvigorated funding approach is needed to accelerate R&D of innovative global health technologies at the US Agency for International Development (USAID).
Emily manages congressional outreach, policy development, and legislative analysis to support the US advocacy work of the coalition. In this capacity, she serves as GHTC’s primary liaison with Congress and helps develop strategies to advance the coalition’s legislative priorities.
Prior to GHTC, she served as the Senior Advocacy Associate for Global Health at World Vision US, building support for global health appropriations and legislation, leading a congressional staff learning trip to Mozambique focused on maternal and child health, and serving as co-chair of the Global Health Council Budget and Policy Roundtable.
Emily discovered her passion for global health advocacy as an undergraduate at the University of Notre Dame, where she founded the first-ever student group dedicated to the fight against neglected tropical diseases (NTDs). After graduating, she joined the Global Network for Neglected Tropical Diseases at the Sabin Vaccine Institute, leading grassroots advocacy and fundraising for the END7 campaign, building more than fifty university chapters in fifteen countries, and spearheading annual student advocacy summits to build support for the USAID NTD Program on Capitol Hill. She also pioneered a faith-based engagement effort that culminated in an international conference on NTDs at the Vatican featuring a message from Pope Francis.
She graduated from Notre Dame with degrees in psychology and theology. In her free time, you can usually find her baking, training for half marathons (to balance said baking) and hosting elaborate dinner parties.
Blog posts written by Emily
Total of 13 blog posts
On November 19, GHTC hosted a virtual roundtable with four organizations advancing COVID-19 innovations and 12 staff members from congressional offices. The dialogue focused on the need for COVID-19 innovations designed for use in low-resource settings and the role the US Agency for International Development (USAID) could play in supporting this effort. Read on for a recap of the event.
This week, months of tense negotiation between leaders in the Democratically-controlled US House of Representatives, the Republican-held Senate, and the White House concluded with the passage of two massive spending packages encompassing all federal government spending for fiscal year (FY) 2020 —nearly three months behind schedule.
Faces of Innovation—a new GHTC project that features scientists on the front lines of research and development on new global health tools and technologies—profiles Dr. James Mutunga, who we met at the American Society of Tropical Medicine and Hygiene (ASTMH) Annual Conference, who does research on developing and testing new methods of controlling vector-borne diseases as well as pathogen surveillance in arthropod disease vectors at the US Army Medical Research Directorate-Africa in Kisumu, Kenya.
Faces of Innovation—a new GHTC project that features scientists on the front lines of research and development on new global health tools and technologies—profiles Dr. Peter Hotez, who we met at the American Society of Tropical Medicine and Hygiene (ASTMH) Annual Conference, who does research to develop vaccines for neglected tropical diseases as professor and Dean of the National School of Tropical Medicine at the Baylor College of Medicine in Houston, Texas.
Congressional briefing highlights Department of Defense’s long war against a surprising enemy: malaria
Most Americans think of malaria as a disease that only threatens people in far-off nations. But with American military personnel deployed in countries all around the globe, malaria remains an ongoing threat to the health of our servicemembers and, by extension, our military readiness.